Intrinsic and extrinsic control of epithelial tissue stem cell activity
上皮组织干细胞活性的内在和外在控制
基本信息
- 批准号:10406792
- 负责人:
- 金额:$ 44.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressBasal CellBiological ModelsCancer EtiologyCell CompartmentationCellsCharacteristicsChromatinColony-Forming Units AssayDiseaseEpithelialEventFailureGene ExpressionGene Expression RegulationGenetic TranscriptionGenomicsHeterogeneityHomeostasisKnowledgeLeadMammary glandMesenchymalMolecularMolecular TargetMorphogenesisNatural regenerationProliferatingProstateRegenerative MedicineRegulationResearchSignal PathwaySignal TransductionSkinTechnologyTestingTissue EngineeringTissuesUndifferentiatedbeta catenincancer cellcell typeclinically relevantin vivoinnovationinsightinterdisciplinary approachknockout genemacrophagemalignant breast neoplasmmammarymammary epitheliumnovelpreventprogramsregenerativeself-renewalsingle cell sequencingstemstem cell biologystem cell genesstem cellstissue regenerationtissue stem cells
项目摘要
PROJECT SUMMARY
Tissue stem cells are rare, undifferentiated cells that are capable of self-renewal and are essential for
fueling the homeostasis and regeneration of the tissue in which they reside. They are often quiescent, and
when activated, they proliferate and differentiate to produce mature cell types with specialized functions. Stem
cell activities are jointly controlled by the intrinsic gene expression program and the signals from the
surrounding tissue microenvironment. Dissecting the intrinsic and extrinsic mechanisms that govern stem cell
quiescence and activation is important not only for gaining fundamental knowledge of tissue and stem cell
biology, but also for understanding how to manipulate cell fates in tissue engineering and regenerative
medicine. Myriad regenerative epithelial tissues, such as mammary gland, skin, and prostate, house stem cells
in their basal cell compartment. We use two mammalian tissues, mammary gland and skin, each with its
unique advantages and clinical relevance, as complimentary model systems to study both general and tissue-
specific mechanisms underlying the regulation of basal cell fate and stem cell activities. Our research has
elucidated the function of key transcription and chromatin factors in mammary and skin basal/stem cell gene
regulation, and how these factors interface with major signaling pathways to control the activation, proliferation,
differentiation, and epithelial-mesenchymal plasticity of basal stem cells. The recent advent of single-cell
sequencing technology has enabled us to systematically probe the cellular and molecular heterogeneities of
mammary and skin basal cells, allowing a deeper and more comprehensive understanding of their
compositions and characteristics as well as providing novel insights into the sequence of events in stem cell
activation and differentiation. In the next five years, we will continue to employ a multi-disciplinary approach
combining single-cell genomics and spatial gene expression mapping with tissue-specific gene knockout and
lineage tracing, in vivo and ex vivo stem cell assays, as well as molecular studies to address two major
knowledge gaps regarding mammary basal stem cells: how their quiescence is maintained and active
expansion is achieved. Specifically, we will test the innovative hypothesis that a low level of Wnt/b-catenin
signaling and molecular cross-talks between basal cells and specific macrophage subsets are critical for
maintaining basal stem cell quiescence. We will also characterize the novel function and regulation of a newly
discovered subset of basal cells as transit amplifying progenitor cells that serve as workhorses to drive basal
cell expansion during mammary epithelial morphogenesis, homeostasis, and regeneration. When and where
applicable, we will perform parallel analysis on skin in order to identify potentially general principles and
strategies underlying basal cell-macrophage cross-talks. Our findings will expose novel intrinsic and extrinsic
regulators of basal stem cell quiescence and active expansion. This knowledge is fundamental to preventing
stem cell depletion and regenerative diseases as well as to understanding cancer cell dormancy.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xing Dai其他文献
Xing Dai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xing Dai', 18)}}的其他基金
Intrinsic and extrinsic control of epithelial tissue stem cell activity
上皮组织干细胞活性的内在和外在控制
- 批准号:
10615883 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
Multiscale Models of Wound Cell Plasticity for Regeneration
伤口细胞再生可塑性的多尺度模型
- 批准号:
10289695 - 财政年份:2021
- 资助金额:
$ 44.8万 - 项目类别:
Multiscale Models of Wound Cell Plasticity for Regeneration
伤口细胞再生可塑性的多尺度模型
- 批准号:
10438606 - 财政年份:2018
- 资助金额:
$ 44.8万 - 项目类别:
Multiscale Models of Wound Cell Plasticity for Regeneration
伤口细胞再生可塑性的多尺度模型
- 批准号:
10210359 - 财政年份:2018
- 资助金额:
$ 44.8万 - 项目类别:
Multiscale Models of Wound Cell Plasticity for Regeneration
伤口细胞再生可塑性的多尺度模型
- 批准号:
10436537 - 财政年份:2018
- 资助金额:
$ 44.8万 - 项目类别:
Multiscale Models of Wound Cell Plasticity for Regeneration
伤口细胞再生可塑性的多尺度模型
- 批准号:
10654206 - 财政年份:2018
- 资助金额:
$ 44.8万 - 项目类别:
Mammary basal/stem cell plasticity and regulation
乳腺基底/干细胞可塑性和调节
- 批准号:
9557556 - 财政年份:2017
- 资助金额:
$ 44.8万 - 项目类别:
Mammary basal/stem cell plasticity and regulation
乳腺基底/干细胞可塑性和调节
- 批准号:
9895082 - 财政年份:2017
- 资助金额:
$ 44.8万 - 项目类别:
Control of epithelial plasticity and differentiation in hair follicle stem/progenitor cells
毛囊干/祖细胞上皮可塑性和分化的控制
- 批准号:
9293894 - 财政年份:2015
- 资助金额:
$ 44.8万 - 项目类别:
Chromatin Regulation of Epithelial Progenitor Cell Self-Renewal by Pygo2
Pygo2 对上皮祖细胞自我更新的染色质调节
- 批准号:
7895610 - 财政年份:2009
- 资助金额:
$ 44.8万 - 项目类别:
相似海外基金
Ancillary SOURCE Study: Characterization of Small Airway Basal Cell Biology in Early COPD
辅助来源研究:早期 COPD 中小气道基底细胞生物学的特征
- 批准号:
10736644 - 财政年份:2023
- 资助金额:
$ 44.8万 - 项目类别:
Map the human airway basal cell niche and the role that FGFR2 plays within it
绘制人类气道基底细胞生态位图以及 FGFR2 在其中发挥的作用
- 批准号:
10752101 - 财政年份:2023
- 资助金额:
$ 44.8万 - 项目类别:
Precision oncology to define basal cell carcinoma (BCC) with high-risk histopathological subtypes
精准肿瘤学定义具有高风险组织病理学亚型的基底细胞癌 (BCC)
- 批准号:
485125 - 财政年份:2023
- 资助金额:
$ 44.8万 - 项目类别:
Operating Grants
Analysis of intraoperative videos from basal cell carcinoma removal surgery
基底细胞癌切除手术术中视频分析
- 批准号:
574060-2022 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
University Undergraduate Student Research Awards
Mechanisms of Basal Cell Dysfunction in Chemical-induced Bronchiolitis Obliterans
化学诱发闭塞性细支气管炎基底细胞功能障碍的机制
- 批准号:
10693404 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
Mechanisms of Basal Cell Dysfunction in Chemical-induced Bronchiolitis Obliterans
化学诱发闭塞性细支气管炎基底细胞功能障碍的机制
- 批准号:
10523626 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
Developing Improved Models of Basal Cell Carcinoma to Evaluate Tumor-Drug Response
开发改进的基底细胞癌模型以评估肿瘤药物反应
- 批准号:
10518702 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
Applied Research and Development Grants - Level 3
Predicting drug response for basal cell carcinoma by comprehensive genomic analysis.
通过综合基因组分析预测基底细胞癌的药物反应。
- 批准号:
21K16898 - 财政年份:2021
- 资助金额:
$ 44.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2021
- 资助金额:
$ 44.8万 - 项目类别:
Applied Research and Development Grants - Level 3














{{item.name}}会员




